TABLE 5.
TRALI and possible TRALI diagnoses by sex, parity, and HLA antibody of the LAPS-II donor whose component was transfused*
Study |
Control |
Total |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Females with
pregnancies |
Females with
pregnancies |
Females with
pregnancies |
|||||||||||
Diagnosis | Male and never-pregnant females (n = 99) | One pregnancy (n = 99) | Two pregnancies (n = 328) | Three or more pregnancies (n = 669) | Male and never-pregnant females (n = 103) | One pregnancy (n = 103) | Two pregnancies (n = 349) | Three or more pregnancies) (n = 678) | Male and never-pregnant females (n = 202) | One pregnancy (n = 202) | Two pregnancies (n = 677) | Three or more pregnancies (n = 1347) | p value† (exact test) |
TRALI | 0 | 0 | 1 (0.30) | 6 (0.90) | 0 | 0 | 0 | 2 (0.29) | 0 | 0 | 1 (0.15) | 8 (0.59) | 0.13 |
Possible TRALI | 1 (1.01) | 2 (2.02) | 2 (0.61) | 4 (0.60) | 0 | 0 | 3 (0.86) | 5 (0.74) | 1 (0.50) | 2 (0.99) | 5 (0.74) | 9 (0.67) | 0.97 |
TRALI or possible TRALI | 1 (1.01) | 2 (2.02) | 3 (0.91) | 10 (1.49) | 0 | 0 | 3 (0.86) | 7 (1.03) | 1 (0.50) | 2 (0.99) | 6 (0.89) | 17 (1.26) | 0.71 |
Data are reported as number (%).
p value is computed only among the total columns and compares rates among the four sex/parity classifications.